Matthew Wein serves as Executive at Metagenomi, Inc., where they oversee executive responsibilities. Since joining the company, Matthew Wein has executed 4 insider transactions totaling $712, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 5, 2025 involved selling 199 shares valued at $352.
Matthew Wein currently holds 115,031 shares of Metagenomi, Inc. (MGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Wein has been a net seller of MGX stock. They have purchased $0 and sold $712 worth of shares.
Matthew Wein's most recent insider trade was on Dec 5, 2025, when they sold 199 shares at $1.77 per share.
Get notified when new Form 4 filings are submitted
| $1.60 |
| Discretionary |
| Sep 5, 2025 | MGX | $360 | Sale | 199 | $1.81 | Discretionary |
| Apr 1, 2024 | MGX | $0 | Award | 10,397 | $N/A | Discretionary |